CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT

Oncology Reports

Volumn 32, Issue 2, 2014, Pages 677-683

  Yu, Wenjun ^a   Wang, Jiayi ^a   Ma, Lifang ^a   Tang, Xun ^a   Qiao, Yongxia ^b   Pan, Quihui ^a   Yu, Yongchun ^c   Sun, Fenyong ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

CD166; Liver cancer; PI3K AKT; Protein stability; Tumorigenesis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR FOXO; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOLIC FRACTION; DOWNSTREAM PROCESSING; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; UBIQUITINATION; ANIMAL; CELL NUCLEUS; CYTOSOL; EXPERIMENTAL LIVER NEOPLASM; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSOL; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; UBIQUITINATION;

EID: 84903145659     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3226     Document Type: Article

References (24)

1. van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, Bloemers HP, Figdor CG and Swart GW: Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276: 25783-25790, 2001.
2. Weichert W, Knösel T, Bellach J, Dietel M and Kristiansen G: ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57: 1160-1164, 2004. (Pubitemid 39486521)
3. Burkhardt M, Mayordomo E, Winzer KJ, Fritzsche F, Gansukh T, Pahl S, Weichert W, Denkert C, Guski H and Dietel MG: Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59: 403-409, 2006.
4. Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, Kenngott HG, Matterne U, Mollberg N, Rahbari NN, Hinz U, Koch M, Aigner M and Weitz J: Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br J Cancer 101: 457-464, 2009.
5. Jezierska A, Matysiak W and Motyl T: ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med Sci Monit 12: BR263-BR273, 2006. (Pubitemid 44186369)
6. Wang J, Gu Z, Ni P, Qiao Y, Chen C, Liu X, Lin J, Chen N and Fan Q: NF-κB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop. Nucleic Acids Res 39: 6440-6455, 2011.
7. Ma L, Wang J, Lin J, Pan Q, Yu Y and Sun F: Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-kinases (PI3K)/AKT signaling to exert its anti-apoptotic role via yes associated protein (YAP) in liver cancer. J Biol Chem: Jan 30, 2014 (Epub ahead of print). doi: 10.1074/jbc.M113.524819.
8. Zhang X, Tang N, Hadden TJ and Rishi AK: Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813: 1978-1986, 2011.
9. Medema RH, Kops GJ, Bos JL and Burgering BM: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787, 2000. (Pubitemid 30212408)
10. Urbich C, Knau A, Fichtlscherer S, Walter DH, Brühl T, Potente M, Hofmann WK, de Vos S, Zeiher AM and Dimmeler S: FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 19: 974-976, 2005. (Pubitemid 40827722)
11. Carbajo-Pescador S, Mauriz JL, García-Palomo A and González-Gallego J: FoxO proteins: regulation and molecular targets in liver cancer. Curr Med Chem 21: 1231-1246, 2014.
12. Wang J, Ma L, Weng W, Qiao Y, Zhang Y, He J, Wang H, Xiao W, Li L, Chu Q, Pan Q, Yu Y and Sun F: Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer. Hepatology 58: 1011-1020, 2013.
13. You H, Yamamoto K and Mak TW: Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc Natl Acad Sci USA 103: 9051-9056, 2006. (Pubitemid 43902531)
14. Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX and Zhang YE: Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121: 101-113, 2005.
15. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH and Massague J: Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441-454, 2007. (Pubitemid 46199289)
16. Fu Z and Tindall DJ: FOXOs, cancer and regulation of apoptosis. Oncogene 27: 2312-2319, 2008. (Pubitemid 351501782)
17. Hales EC, Taub JW and Matherly LH: New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Cell Signal 26: 149-161, 2014.
18. Lin A, Yao J, Zhuang L, Wang D, Han J, Lam EW, TCGA Research Network and Gan B: The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress. Oncogene: Jul 15, 2013 (Epub ahead of print). doi: 10.1038/onc.2013.273.
19. Tao GZ, Lehwald N, Jang KY, Baek J, Xu B, Omary MB and Sylvester KG: Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. J Biol Chem 28: 17214-17224, 2013.
20. Yusuf I, Zhu X, Kharas MGs, Chen J and Fruman DA: Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104: 784-787, 2004. (Pubitemid 38970574)
21. Wang J, Zhang Y, Weng W, Qiao Y, Ma L, Xiao W, Yu Y, Pan Q and Sun F: Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer. J Biol Chem 288: 33667-33681, 2013.
22. Wang J, Park JS, Wei Y, Rajurkar M, Cotton JL, Fan Q, Lewis BC, Ji H and Mao J: TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function. Mol Cell 51: 211-225, 2013.
23. Zanella F, Renner O, García B, Callejas S, Dopazo A, Peregrina S, Carnero A and Link W: Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells. Oncogene 29: 2973-2982, 2010.
24. Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274, 2007. (Pubitemid 46962095)